Radiotherapeutic treatment options for oligotopic malignant liver lesions

Radiotherapeutic treatment options for oligotopic malignant liver lesions

Abstract Background Several radiotherapeutic approaches for patients with oligotopic malignant liver lesions unfit for surgical resection exist. The most advanced competitive techniques are high-dose-rate (HDR) brachytherapy, Cyberknife, volume-modulated-arc therapy (VMAT) and Tomotherapy. We evalua...

Full description

Bibliographic Details
Main Authors:	Peter Wust, Marcus Beck, Robert Dabrowski, Oliver Neumann, Sebastian Zschaeck, David Kaul, Dominik P. Modest, Carmen Stromberger, Bernhard Gebauer, Pirus Ghadjar
Format:	Article
Language:	English
Published:	BMC 2021-03-01
Series:	Radiation Oncology
Subjects:	Liver metastasis Oligometastasis Brachytherapy Radiation therapy Colorectal cancer
Online Access:	https://doi.org/10.1186/s13014-021-01779-5

Similar Items

Prognostic Utility of Histological Growth Patterns of Colorectal Lung Oligometastasis
by: Son Jae Yeong, et al.
Published: (2018-03-01)

Indian Brachytherapy Society Guidelines for radiotherapeutic management of cervical cancer with special emphasis on high-dose-rate brachytherapy
by: Umesh Mahantshetty, et al.
Published: (2019-08-01)

Proposal for a definition of "Oligometastatic disease in pancreatic cancer"
by: Alexander I. Damanakis, et al.
Published: (2019-12-01)

Resected case of stage IV pleomorphic carcinoma of the lung with long-term survival
by: Haruki Choshi, et al.
Published: (2020-05-01)

A Review of Ongoing Trials of Stereotactic Ablative Radiotherapy for Oligometastatic Cancers: Where Will the Evidence Lead?
by: Faiez Al-Shafa, et al.
Published: (2019-06-01)

Oligometastatic Adenocarcinoma of the Esophagus: Current Understanding, Diagnosis, and Therapeutic Strategies
by: Michael P. Rogers, et al.
Published: (2021-08-01)

Evaluating single-institution resource costs of consolidative radiotherapy for oligometastatic non-small cell lung cancer using time-driven activity-based costing
by: Todd A. Pezzi, et al.
Published: (2020-07-01)

Limited Liver or Lung Colorectal Cancer Metastases. Systemic Treatment, Surgery, Ablation or SBRT
by: Meritxell Molla, et al.
Published: (2021-05-01)

Durable biochemical response following adrenal metastasectomy for oligometastatic castrate-resistant prostate cancer
by: Akbar N. Ashrafi, et al.
Published: (2020-09-01)

Long-term survival with repeat resection for lung oligometastasis from pancreatic ductal adenocarcinoma: a case report
by: Ryota Matsuki, et al.
Published: (2018-03-01)

Treatment of Cancer with Radio-Immunotherapy: What We Currently Know and What the Future May Hold
by: William Tyler Turchan, et al.
Published: (2021-09-01)

An adrenal incidentaloma caused by synchronous and isolated metastasis
by: Koichiro Yamamoto, et al.
Published: (2021-04-01)

Small cell lung cancer with thyroid gland oligometastasis: A case report
by: Toshiharu Tsutsui, et al.
Published: (2021-02-01)

Oligometastasis and local ablation in the era of systemic targeted and immunotherapy
by: Rosario Mazzola, et al.
Published: (2020-05-01)

The utility of FDG-PET for assessing outcomes in oligometastatic cancer patients treated with stereotactic body radiotherapy: a cohort study
by: Solanki Abhishek A, et al.
Published: (2012-12-01)

Papillary Thyroid Carcinoma Metastases Presenting as Ipsilateral Adrenal Mass and Renal Cyst
by: Serge Ginzburg, et al.
Published: (2015-11-01)

Physical analysis of temperature-dependent effects of amplitude-modulated electromagnetic hyperthermia
by: Peter Wust, et al.
Published: (2019-01-01)

Efficacy of Local Therapy for Oligometastatic Hepatocellular Carcinoma: A Propensity Score Matched Analysis
by: Kim K, et al.
Published: (2021-02-01)

Metastasis-Directed Radiotherapy for Oligoprogressive Castration-Resistant Prostate Cancer Recurrence Revealed by Choline PET/CT
by: Kazuhiro Kitajima, et al.
Published: (2021-01-01)

Stereotactic ablative radiotherapy and systemic treatments for extracerebral oligometastases, oligorecurrence, oligopersistence and oligoprogression from lung cancer
by: Manon Kissel, et al.
Published: (2019-12-01)

Hypofractionated Image-Guided Radiation Therapy With Simultaneous-Integrated Boost Technique for Limited Metastases: A Multi-Institutional Analysis
by: Corbin D. Jacobs, et al.
Published: (2019-06-01)

Two cases of oligometastatic castration‐resistant prostate cancer detected by diffusion‐weighted whole‐body imaging with background body signal suppression
by: Yuki Shimizu, et al.
Published: (2020-03-01)

Stereotactic Radiotherapy for Oligometastasis
by: Sotaro Otake, et al.
Published: (2019-01-01)

Osseous oligometastases from thymic carcinoma: a case report suggesting the effectiveness of palliative-intent radiotherapy treatment
by: Kashima J, et al.
Published: (2016-02-01)

Hypofractionated radiotherapy for primary or secondary oligometastatic lung cancer using Tomotherapy
by: Chang Heng-Jui, et al.
Published: (2012-12-01)

Treatment Strategies for High-Risk Localized and Locally Advanced and Oligometastatic Prostate Cancer
by: Tomoyuki Makino, et al.
Published: (2021-09-01)

Proposed Definition for Oligometastatic Recurrence in Biliary Tract Cancer Based on Results of Locoregional Treatment: A Propensity-Score-Stratified Analysis
by: Morino, Koshiro
Published: (2021)

Adrenal oligometastasis cured with stereotactic ablative radiotherapy
by: Julia Malone, BSC, et al.
Published: (2020-11-01)

Pulmonary large cell neuroendocrine carcinoma with adrenal oligorecurrence successfully treated by adrenalectomy
by: Hiroki Sato, et al.
Published: (2020-08-01)

Management of Synchronous Extrathoracic Oligometastatic Non-Small Cell Lung Cancer
by: Gregory D. Jones, et al.
Published: (2021-04-01)

Role of high-dose salvage radiotherapy for oligometastases of the localised abdominal/pelvic lymph nodes: a retrospective study
by: Makoto Ito, et al.
Published: (2020-06-01)

Recursive partitioning analysis of patients with oligometastatic non-small cell lung cancer: a retrospective study
by: Jia-Tao Zhang, et al.
Published: (2019-11-01)

A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)
by: Noura Radwan, et al.
Published: (2017-06-01)

CyberKnife Stereotactic Ablative Radiotherapy for Recurrent or Oligometastatic Gynecological Cancers
by: Tejinder Kataria, et al.
Published: (2021-04-01)

Genetic Analysis and Operative Outcomes in Patients with Oncogene-Driven Advanced NSCLC Treated with Cytoreductive Surgery as a Component of Local Consolidative Therapy
by: Byung Jo Park, et al.
Published: (2021-05-01)

High-Risk Localized and Locally Advanced Prostate Cancer
Published: (2023)

Renal cell carcinoma lung metastases treated by radiofrequency ablation integrated with systemic treatments: over 10 years of experience
by: Alexis Gonnet, et al.
Published: (2019-12-01)

Radioablation +/− hormonotherapy for prostate cancer oligorecurrences (Radiosa trial): potential of imaging and biology (AIRC IG-22159)
by: Giulia Marvaso, et al.
Published: (2019-09-01)

A Case of Solitary Lung Metastasis of Breast Cancer Successfully Treated with Stereotactic Body Radiotherapy after Chemotherapy
by: Shoji Oura, et al.
Published: (2020-04-01)

Complete biochemical response following metastasis-directed radiotherapy for oligometastatic prostate cancer: A case report
by: Satoshi Okuda, et al.
Published: (2020-11-01)